Skip to main content
logo
BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.200
+0.050 (4.35%)
At close: Apr 20, 2026, 4:00 PM EDT
1.190
-0.010 (-0.83%)
Pre-market: Apr 21, 2026, 5:32 AM EDT

BioXcel Therapeutics Revenue

In the year 2025, BioXcel Therapeutics had annual revenue of $642.00K, down -71.67%. BioXcel Therapeutics had revenue of $256.00K in the quarter ending December 31, 2025, a decrease of -30.05%.

Revenue (ttm)
$642.00K
Revenue Growth
-71.67%
P/S Ratio
50.61
Revenue / Employee
$22,138
Employees
29
Market Cap
32.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025642.00K-1.62M-71.67%
Dec 31, 20242.27M886.00K64.20%
Dec 31, 20231.38M1.01M268.00%
Dec 31, 2022375.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure72.16M
Rockwell Medical69.26M
Aytu BioPharma62.64M
Cumberland Pharmaceuticals44.52M
Zhengye Biotechnology Holding21.46M
SCYNEXIS20.60M
China Pharma Holdings4.14M
TherapeuticsMD3.02M
Revenue Rankings

BTAI News

More News